Capstone Investment Advisors’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-61,790
Closed -$232K 2360
2024
Q1
$232K Buy
61,790
+42,949
+228% +$251K ﹤0.01% 1953
2023
Q4
$185K Buy
+18,841
New +$154K ﹤0.01% 1807
2022
Q2
Sell
-10,498
Closed -$96K 2035
2022
Q1
$96K Buy
+10,498
New +$121K ﹤0.01% 1858
2020
Q1
Sell
-205,337
Closed -$1.05M 1328
2019
Q4
$1.05M Sell
205,337
-15,108
-7% -$76.8K 0.01% 989
2019
Q3
$1.14M Sell
220,445
-231,785
-51% -$1.3M 0.01% 897
2019
Q2
$2.74M Buy
452,230
+204,917
+83% +$1.44M 0.02% 653
2019
Q1
$1.79M Sell
247,313
-370,579
-60% -$2.68M 0.02% 648
2018
Q4
$4.57M Buy
+617,892
New +$3.91M 0.06% 259
2016
Q3
Sell
-18,500
Closed -$130K 876
2016
Q2
$130K Buy
+18,500
New +$169K ﹤0.01% 642

Other funds holding PACB